Australia

Plasma-Derived Therapies

Product Name Subcategory Description Business
ALBUMEX®  4 Critical Care Used when the blood volume is low, during heart-lung bypass surgery, and in plasma exchange. CSL Behring Australia
ALBUMEX® 20 Critical Care Used when quantity of albumin in blood is low, for resuscitation in shock, in extensive burns, respiratory distress syndrome, blood purification and plasma exchange. CSL Behring Australia
BERINERT® Critical Care Used for the treatment of acute attacks in patients with hereditary angioedema. CSL Behring Australia
BIOSTATE® Coagulation Disorders Used for patients with haemophilia A, in which there are reduced levels of factor VIII. CSL Behring Australia
CMV Immunoglobulin-VF Immune Therapy Used to help prevent cytomegalovirus infection in specific transplant patients. CSL Behring Australia
EVOGAM® Immune Therapy Used to treat people who need replacement of antibodies which form part of our immune system and can provide protection against some infections CSL Behring Australia
Hepatitis B Immunoglobulin-VF Immune Therapy Used to help prevent hepatitis B infection in a person who comes into contact with suspected infected material. CSL Behring Australia
Hizentra® Immune Therapy Used to treat patients who need replacement of antibodies. Antibodies are part of the immune system and help provide protection against infections. CSL Behring Australia
INTRAGAM® P Immune Therapy Used to replace antibodies to help prevent infections and also used in the treatment of some autoimmune disorders. CSL Behring Australia
INTRAGAM® 10 Immune Therapy Indicated to replace antibodies to help prevent infections and also in the treatment of some autoimmune disorders. CSL Behring Australia
MonoFIX®-VF Coagulation Disorders Used in patients with haemophilia B, in which there are reduced levels of Factor IX. CSL Behring Australia
Normal Immunoglobulin-VF Immune Therapy Used for the replacement of antibodies to help prevent infections. CSL Behring Australia
Privigen® Immune Therapy Used to treat patients who need replacement of antibodies and for the treatment of some autoimmune disorders. CSL Behring Australia
PROTHROMBINEX®-VF Coagulation Disorders Used for the prevention and treatment of bleeding in patients with reduced levels of factor IX, II or X. CSL Behring Australia
Rh(D) Immunoglobulin-VF Immune Therapy Used to prevent Haemolytic Disease of the Newborn. CSL Behring Australia
RHOPHYLAC® Immune Therapy Used in large fetomaternal haemorrhage (FMH), or for inadvertent or emergency transfusion of Rh (D) positive blood to an Rh (D) negative female of childbearing potential. CSL Behring Australia
RiaSTAP® Coagulation Disorders Used for treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency. CSL Behring Australia
Tetanus Immunoglobulin-VF IM Immune Therapy Used to help prevent tetanus in a person who has not recently been immunised against tetanus. CSL Behring Australia
Tetanus Immunoglobulin-VF IV Immune Therapy Used to treat tetanus infection. CSL Behring Australia
THROMBOTROL®-VF Critical Care Used for the treatment of patients with conditions relating to an inherited deficiency of antithrombin III. CSL Behring Australia
Zoster Immunoglobulin-VF Immune Therapy Used to help prevent chickenpox and shingles. CSL Behring Australia

Australia

Vaccines

Product Name Subcategory Description Business
Afluria® Quad   For the prevention of influenza in persons aged 18 years and over. Seqirus
ADT® Booster   For the prevention of diphtheria and tetanus. Seqirus
Dukoral®   For the prevention of Cholera caused by serogroup O1 Vibrio cholera in adults and children ≥ 2 years. Seqirus
Fluvax®   For the prevention of influenza. Seqirus
Gardasil®   For the prevention of cervical, vulvar, vaginal and anal cancer, and genital warts caused by Human Papillomavirus (HPV) Types 6,11,16 & 18. Seqirus
H-B-VAX II®   For the prevention of hepatitis B infection. Seqirus
Jespect®   For the prevention of Japanese Encephalitis infection Seqirus
M-M-R® II   For the prevention of measles, mumps and rubella. Seqirus
Menveo®   For the prevention of invasive disease caused by Neisseria meningitidis serogroups A, C, W-135 and Y. Seqirus
ProQuad®   For the prevention of measles, mumps, rubella and chickenpox. Seqirus
Pneumovax® 23   For the prevention of pneumococcal infections. Seqirus
Q-Vax®   For the prevention of Q fever. Seqirus
RotaTeq®   For the prevention of gastroenteritis. Seqirus
Vaqta®   For the prevention of hepatitis A infection. Seqirus
VARIVAX® Refrigerated   For the prevention of chickenpox. Seqirus
Vivotif Oral®   For the prevention of typhoid. Seqirus
ZOSTAVAX®   For the prevention of shingles. Seqirus

Australia

Pharmaceuticals

Product Name Subcategory Description Business
ACARIZAX® Immune Therapy For the treatment of house dust mite respiratory allergy Seqirus
BENPEN® Antibiotics Used to treat infections caused by susceptible bacteria. Seqirus
Burinex® Urology Indicated for the treatment of oedema, particularly when associated with congestive heart failure, hepatic and renal diseases. Seqirus
Caldolor® Analgesia For management of post-operative pain and fever Seqirus
Fucidin® Antibiotics Used to treat serious infections caused by susceptible bacteria that have not responded to other antibiotics. Seqirus
Palexia® SR Analgesia Indicated for the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia. Seqirus
Palexia® IR Analgesia Indicated for the relief of moderate to severe pain. Seqirus
Versatis® Analgesia For the symptomatic relief of neuropathic pain associated with previous herpes zoster infection (postherpetic neuralgia, PHN) Seqirus
Tramal® Analgesia Used to treat moderate to severe pain. Seqirus

Australia

Antivenoms

Product Name Subcategory Description Business
Black Snake Antivenom   For the treatment of symptoms of a venomous bite. Seqirus
Box Jellyfish Antivenom   For the treatment of symptoms of a venomous sting. Seqirus
Brown Snake Antivenom   For the treatment of symptoms of a venomous bite. Seqirus
Death Adder Antivenom   For the treatment of symptoms of a venomous bite. Seqirus
Funnel Web Spider Antivenom   For the treatment of symptoms of a venomous bite. Seqirus
Polyvalent Snake Antivenom   For the treatment of symptoms of a venomous bite. Seqirus
Red Back Spider Antivenom   For the treatment of symptoms of a venomous bite. Seqirus
Sea Snake Antivenom   For the treatment of symptoms of a venomous bite. Seqirus
Stonefish Antivenom   For the treatment of symptoms of a venomous sting. Seqirus
Taipan Snake Antivenom   For the treatment of symptoms of a venomous bite. Seqirus
Tiger Snake Antivenom   For the treatment of symptoms of a venomous bite. Seqirus

Australia

Immunohaematology (Diagnostic Reagents)

Product Name Subcategory Description Business
A2 Cells 3% Reagent Red Blood Cells Used to detect ABO blood group antibodies and identifying A1 and A2 subgroups. Seqirus Immunohaematology
Abtectcell™ II 0.8% Reagent Red Blood Cells Used to detect unexpected alloantibodies using Column Agglutination Technology (CAT) Systems. Seqirus Immunohaematology
Abtectcell™ II 0.8% Pooled Reagent Red Blood Cells Used in detecting unexpected alloantibodies. Seqirus Immunohaematology
Abtectcell™ II 3% Reagent Red Blood Cells Used to detect unexpected alloantibodies using tube technique. Seqirus Immunohaematology
Abtectcell™ III 0.8% Reagent Red Blood Cells Used to detect unexpected alloantibodies using Column Agglutination Technology (CAT) Systems. Seqirus Immunohaematology
Abtectcell™ III 0.8% RhD Negative Screening Cells Reagent Red Blood Cells Used in detecting unexpected alloantibodies other than anti-D. Seqirus Immunohaematology
Abtectcell™ III 3% Reagent Red Blood Cells Used to detect unexpected alloantibodies using tube technique. Seqirus Immunohaematology
AHG Anti-IgG Anti-Human Globulin Reagent Used for detection of clinically relevant IgG subtypes. Seqirus Immunohaematology
AHG Control Cells 3% Reagent Red Blood Cells Used for the confirmation of antiglobulin activity. Seqirus Immunohaematology
Anti-A1 ABO Reagent Used to detect Group A1 red cells. Seqirus Immunohaematology
Anti-Fya Phenotyping Reagent Used to detect the presence of the Fya antigen on human red cells. Seqirus Immunohaematology
Anti-Fyb Phenotyping Reagent Used to detect the presence of the Fyb antigen on human red cells. Seqirus Immunohaematology
Anti-k (Cellano) Phenotyping Reagent Used to detect the presence of the k (Cellano) antigen on human red cells. Seqirus Immunohaematology
Anti-Kpa Phenotyping Reagent Used to detect the presence of the Kpa antigen on human red cells. Seqirus Immunohaematology
Bovine Albumin 30% Solution Supplementary Reagent Used to enhance the agglutination of red cells in antibody detection tests. Seqirus Immunohaematology
Celpresol™ Supplementary Reagent Designed for the preservation, suspension and resuscitation of human red blood cells. Seqirus Immunohaematology
Celpresol™ LISS Supplementary Reagent Designed for the preservation, suspension and resuscitation of human red blood cells. Seqirus Immunohaematology
Controcell™ 2
(EU and US only)
Reagent Red Blood Cells Designed to control, standardise and validate all routine immunohaematology tests. Seqirus Immunohaematology
Controcell™ 4
(EU and US only)
Reagent Red Blood Cells Designed to control, standardise and validate all routine immunohaematology tests. Seqirus Immunohaematology
Cord Cells 3% Reagent Red Blood Cells Used for confirming the presence of anti-I in an antibody identification procedure. Seqirus Immunohaematology
Epiclone™ AHG Poly Anti-Human Globulin Reagent Used for detection of clinically relevant IgG subtypes. Seqirus Immunohaematology
Epiclone™ Anti-A ABO Reagent Used to detect the presence of the A antigen on human red cells. Seqirus Immunohaematology
Epiclone™ Anti-A/B ABO Reagent Used to detect the presence of the A and B antigens on human red cells. Seqirus Immunohaematology
Epiclone™ Anti-B ABO Reagent Used to detect the presence of the B antigen on human red cells. Seqirus Immunohaematology
Epiclone™ Anti-C Phenotyping Reagent Used to detect the presence of the C antigen on human red cells. Seqirus Immunohaematology
Epiclone™ Anti-c Phenotyping Reagent Used to detect the presence of the c antigen on human red cells. Seqirus Immunohaematology
Epiclone™ Anti-C3d Anti-Human Globulin Reagent Used to only detect the clinically relevant complement components in relation to Anti-C3d. Seqirus Immunohaematology
Epiclone™ Anti-Cw Phenotyping Reagent Used to detect the presence of the Cw antigen on human red cells. Seqirus Immunohaematology
Epiclone™ Anti-DCE Phenotyping Reagent Used to detect the presence of the D, C and E antigens on human red cells. Seqirus Immunohaematology
Epiclone™ Anti-E Phenotyping Reagent Used to detect the presence of the E antigen on human red cells. Seqirus Immunohaematology
Epiclone™ Anti-e Phenotyping Reagent Used to detect the presence of the e antigen on human red cells. Seqirus Immunohaematology
Epiclone™ Anti-Jka Phenotyping Reagent Used to detect the presence of the Jka antigen on human red cells. Seqirus Immunohaematology
Epiclone™ Anti-Jkb Phenotyping Reagent Used to detect the presence of the Jkb antigen on human red cells. Seqirus Immunohaematology
Epiclone™ Anti-K (Kell) Phenotyping Reagent Used to detect the presence of the K antigen on human red cells. Seqirus Immunohaematology
Epiclone™ Anti-Lea Phenotyping Reagent Used to detect the presence of the Lea antigen on human red cells. Seqirus Immunohaematology
Epiclone™ Anti-Leb Phenotyping Reagent Used to detect the presence of the Leb antigen on human red cells. Seqirus Immunohaematology
Epiclone™ Anti-M Phenotyping Reagent Used to detect the presence of the M antigen on human red cells. Seqirus Immunohaematology
Epiclone™ Anti-N Phenotyping Reagent Used to detect the presence of the N antigen on human red cells. Seqirus Immunohaematology
Epiclone™ Anti-P1 Phenotyping Reagent Used to detect the presence of the P1 antigen on red blood cells. Seqirus Immunohaematology
Epiclone™ Anti-s Phenotyping Reagent Used to detect the presence of the s antigen on human red cells. Seqirus Immunohaematology
Epiclone™ Anti-S Phenotyping Reagent Used to detect the presence of the S antigen on human red cells. Seqirus Immunohaematology
Epiclone™-2 Anti-D (IgM) RhD Reagent Used to detect the presence of RhD positive human red cells. Seqirus Immunohaematology
Epiclone™-2 Anti-D (IgM/IgG) RhD Reagent Designed for routine RhD typing of human red cells. Seqirus Immunohaematology
Papain Solution Supplementary Reagent Used to treat human red cells in immunohaematological testing. Seqirus Immunohaematology
Phenocell™ 0.8% Reagent Red Blood Cells Used in identification of unexpected alloantibodies using Column Agglutination Technology (CAT) Systems. Seqirus Immunohaematology
Phenocell™ 3% Reagent Red Blood Cells Used in identification of unexpected alloantibodies using tube technique. Seqirus Immunohaematology
Phenocell 0.8% (C Panel) Reagent Red Blood Cells Used in identification of unexpected rare and unusual alloantibodies using Column Agglutination Technology (CAT) Systems. Seqirus Immunohaematology
Phenocell 3% (C Panel) Reagent Red Blood Cells Used in identification of unexpected rare and unusual alloantibodies using tube technique. Seqirus Immunohaematology
RAM Supplementary Reagent Designed for use in tube technique antibody screening, identification and cross matching. Seqirus Immunohaematology
RAMPEG Supplementary Reagent Designed for use in tube technique antibody screening and identification. Seqirus Immunohaematology
Revercell™ 0.8% Reagent Red Blood Cells Used to detect ABO blood group antibodies using Column Agglutination Technology (CAT) Systems. Seqirus Immunohaematology
Revercell™ 15% Reagent Red Blood Cells Used to detect ABO blood group antibodies using tile techniques. Seqirus Immunohaematology
Revercell™ 3% Reagent Red Blood Cells Used to detect ABO blood group antibodies using tube techniques. Seqirus Immunohaematology
Securacell™ Reagent Red Blood Cells Designed to control, standardise and validate all routine immunohaematology tests. Seqirus Immunohaematology
Securacell™ Light Reagent Red Blood Cells Designed to control, standardise and validate all routine immunohaematology tests. Seqirus Immunohaematology
Snake Venom Detection Kit (SVDK) Snake Venom Detection Designed to assist in selection of most appropriate monovalent antivenom therapy. Seqirus Immunohaematology


Austria

Austria Products

To Find More About Austria Products click on Austria General Product Info


Brazil

Brazil Products

To Find More About Brazil Products click on Brazil General Product Info


China

China Products

To Find More About China Products click on China General Product Info


Germany

Germany Products

To Find More About Germany Products click on Germany General Product Info


Hong Kong

Plasma-Derived Therapies

Product Name Subcategory Description Business
BIOSTATE® Coagulation Disorders Used for patients with haemophilia A, in which there are reduced levels of factor VIII. CSL Behring Australia
ALEVIATE® Coagulation Disorders Used for patients with haemophilia A or von Willebrand disease, in which there are reduced levels of factor VIII or von Willebrand factor respectively. CSL Behring Australia
PROTHROMBINEX®-VF Coagulation Disorders Used for the prevention and treatment of bleeding in patients with reduced levels of factor IX, II or X. CSL Behring Australia
 Albumex® 5 Critical Care Used when the blood volume is low, during heart-lung bypass surgery, and in plasma exchange. CSL Behring Australia
Albumex®20 Critical Care Used when quantity of albumin in blood is low, for resuscitation in shock, in extensive burns, respiratory distress syndrome, blood purification and plasma exchange. CSL Behring Australia
INTRAGAM® P Immune Therapy Used to replace antibodies to help prevent infections and also used in the treatment of some autoimmune disorders. CSL Behring Australia


India

Immunohaematology (Diagnostic Reagents)

Product Name Subcategory Description Business
Epiclone™ Anti-A FFMU Concentrate ABO Reagent Concentrated formulation of ABO blood grouping materials for further manufacturing use. Seqirus Immunohaematology
Epiclone™ Anti-B FFMU Concentrate ABO Reagent Concentrated formulation of ABO blood grouping materials for further manufacturing use. Seqirus Immunohaematology
Epiclone™ Anti-A/B FFMU Concentrate ABO Reagent Concentrated formulation of ABO blood grouping materials for further manufacturing use. Seqirus Immunohaematology
Epiclone™ Anti-C3d FFMU Concentrate Anti-Human Globulin Reagent Concentrated formulation of Anti-C3d blood grouping materials for further manufacturing use. Seqirus Immunohaematology
Epiclone™-2 Anti-D (IgM) FFMU Concentrate RhD Reagent Concentrated formulation of RhD blood grouping materials for further manufacturing use. Seqirus Immunohaematology
Epiclone™ Anti-D (IgG) FFMU Concentrate RhD Reagent Concentrated formulation of RhD blood grouping materials for further manufacturing use. Seqirus Immunohaematology
Epiclone™-2 Anti-D (IgM/IgG) FFMU Concentrate RhD Reagent Concentrated formulation of RhD blood grouping materials for further manufacturing use. Seqirus Immunohaematology
Epiclone™ Anti-ABO FFMU Concentrate Diluting Buffer Supplementary Reagent Diluting buffer powder containing a formulation of components to manufacture an appropriate Diluent Reagent for making up FFMU Concentrates into finished reagents. Seqirus Immunohaematology
Epiclone™ Anti-D FFMU Concentrate Diluting Buffer Supplementary Reagent Diluting buffer powder containing a formulation of components to manufacture an appropriate Diluent Reagent for making up FFMU Concentrates into finished reagents. Seqirus Immunohaematology


Italy

Italy Products

To Find More About Italy Products click on Italy General Product Info


Japan

Japan Products

To Find More About Japan Products click on Japan General Product Info


Malaysia

Plasma-Derived Therapies

Product Name Subcategory Description Business
BIOSTATE™ Coagulation Disorders Used for patients with haemophilia A, in which there are reduced levels of factor VIII. CSL Behring Australia
PROTHROMBINEX®-VF Coagulation Disorders Used for the prevention and treatment of bleeding in patients with reduced levels of factor IX, II or X. CSL Behring Australia
ALBUMEX® 20 Critical Care Used when quantity of albumin in blood is low, for resuscitation in shock, in extensive burns, respiratory distress syndrome, blood purification and plasma exchange. CSL Behring Australia
INTRAGAM® P Immune Therapy Used to replace antibodies to help prevent infections and also used in the treatment of some autoimmune disorders. CSL Behring Australia


Mexico

Mexico Products

To Find More About Mexico Products click on Mexico General Product Info


New Zealand

Vaccines

To Find More About Vaccines click on New Zealand General Product Info

New Zealand

Pharmaceuticals

To Find More About Pharmaceuticals click on New Zealand General Product Info

New Zealand

Plasma-Derived Therapies

Product Name Subcategory Description Business
ALBUMEX® 20 Critical Care Used when quantity of albumin in blood is low, for resuscitation in shock, in extensive burns, respiratory distress syndrome, blood purification and plasma exchange. CSL Behring Australia
ALBUMEX®  4 Critical Care Used when the blood volume is low, during heart-lung bypass surgery, and in plasma exchange. CSL Behring Australia
BIOSTATE® Coagulation Disorders Used for patients with haemophilia A or von Willebrand disorder, in which there are reduced levels of factor VIII or von Willebrand factor respectively. CSL Behring Australia
EVOGAM® Immune Therapy Used to treat patients who need replacement of antibodies which form part of our immune system. CSL Behring Australia
Hepatitis B Immunoglobulin-VF Immune Therapy Used to help prevent hepatitis B infection in a person who comes into contact with suspected infected material. CSL Behring Australia
Hizentra® Immune Therapy Used to treat patients who need replacement of antibodies. Antibodies are part of the immune system and help provide protection against infections. CSL Behring Australia
INTRAGAM® P Immune Therapy Used to replace antibodies to help prevent infections and also used in the treatment of some autoimmune disorders. CSL Behring Australia
MonoFIX®-VF Coagulation Disorders Used in patients with haemophilia B, in which there are reduced levels of Factor IX. CSL Behring Australia
Normal Immunoglobulin-VF Immune Therapy Used for the replacement of antibodies to help prevent infections. CSL Behring Australia
Privigen® Immune Therapy Used to treat patients who need replacement of antibodies and for the treatment of some autoimmune disorders. CSL Behring Australia
PROTHROMBINEX®-VF Coagulation Disorders Used for the prevention and treatment of bleeding in patients with reduced levels of factor IX, II or X. CSL Behring Australia
Rh(D) Immunoglobulin-VF Immune Therapy Used to prevent Haemolytic Disease of the Newborn. CSL Behring Australia
RiaSTAP® Coagulation Disorders Used for treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency. CSL Behring Australia
Tetanus Immunoglobulin-VF IM Immune Therapy Used to help prevent tetanus in a person who has not recently been immunised against tetanus. CSL Behring Australia
THROMBOTROL®-VF Critical Care Used for the treatment of patients with conditions relating to an inherited deficiency of antithrombin III. CSL Behring Australia
Zoster Immunoglobulin-VF Immune Therapy Used to help prevent chickenpox and shingles. CSL Behring Australia


Nordic

Nordic Products

To Find More About Nordic Products click on Nordic General Product Info


Singapore

Plasma-Derived Therapies

Product Name Subcategory Description Business
BIOSTATE® Coagulation Disorders Used for patients with haemophilia A, in which there are reduced levels of factor VIII. CSL Behring Australia
ALBUMEX® 20 Critical Care Used when quantity of albumin in blood is low, for resuscitation in shock, in extensive burns, respiratory distress syndrome, blood purification and plasma exchange. CSL Behring Australia
INTRAGAM® P Immune Therapy Used to replace antibodies to help prevent infections and also used in the treatment of some autoimmune disorders. CSL Behring Australia


Spain

Spain Products

To Find More About Spain Products click on Spain General Product Info


Switzerland

Switzerland Products

To Find More About Switzerland Products click on Switzerland General Product Info


United Kingdom

United Kingdom Products

To Find More About United Kingdom Products click on UK General Product Info


United States

United States Products

To Find More About United States Products click on USA General Product Info
© 2016 CSL Limited